课题基金 / 基金详情

项目摘要

项目成果

BEVERLY S EMANUEL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): 1. Services Offered A. Establish lymphoblastoid cell lines from patients with congenital heart defects. B. Isolate DNA from established cell lines, peripheral blood, blood spots, tissues or cheek swabs. C. Perform FISH to screen for 22q11.2 deletions in ?at-risk" patients. D. Regionally localize newly identified human cDNAs by FISH. E. Provide support for microarray-based experiments. F. Provide genotyping/mutation services for the SCCOR. 2. Functions of the Core Unit as a Resource to the SCCOR Core D will provide the cell culture, DNA isolation, cytogenetic and DNA analysis support for the projects and cores in this SCOR. The change in title to the proposed Cell Culture and DNA Analysis Core reflects the changes in program goals and in the scope and emphasis on new genetic analysis services to be provided by this Core. The routine activities of Core D will include the establishment of cell lines, FISH analysis of DNA specimens for 22q11 deletion, preparation of slides for chromosomal in situ hybridization, gene localization by FISH and isolation of high molecular weight DNA samples from patient samples and cell lines. The also Core will provide investigators access to labeled BAC or cosmid clones for FISH as required. On the DNA analysis side, the Core will provide a centralized source for specialized services, technical expertise and reagents to support the DNA analysis (microarray and genotyping) requirements of the investigators in the SCCOR. The Facility will provide access to equipment and technologies that would be prohibitively expensive for an investigator to possess in an individual laboratory. In addition, the Core Unit Leader and staff will provide training and consultation services to the SCCOR investigators and provide training to young and mid-level investigators in genetic laboratory methods and procedures. The following sections briefly summarize the Core functions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Dissection of the 22q11.2 Deletion Syndrome
  • 批准号:
    10473894
  • 项目类别:
  • 资助金额:
    $53.7万
  • 财政年份:
    2018
  • 负责人:
    BEVERLY S EMANUEL
  • 依托单位:
Molecular Dissection of the 22q11.2 Deletion Syndrome
  • 批准号:
    10296523
  • 项目类别:
  • 资助金额:
    $53.7万
  • 财政年份:
    2018
  • 负责人:
    BEVERLY S EMANUEL
  • 依托单位:
Molecular Dissection of the 22q11.2 Deletion Syndrome
  • 批准号:
    9763601
  • 项目类别:
  • 资助金额:
    $40.97万
  • 财政年份:
    2018
  • 负责人:
    BEVERLY S EMANUEL
  • 依托单位:
2/2 Brain, Behavior and Genetic Studies of the 22q11 Deletion Studies
  • 批准号:
    8690149
  • 项目类别:
  • 资助金额:
    $88.33万
  • 财政年份:
    2010
  • 负责人:
    BEVERLY S EMANUEL
  • 依托单位:
国内基金
海外基金
22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
  • 批准号:
    82370906
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    代杰文
  • 依托单位:
22q11.2微缺失综合症中T盒转录因子Tbx1与信号接头蛋白Crkl遗传相互作用致肺动脉发育不良缺陷的机制研究
  • 批准号:
    81170153
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2011
  • 负责人:
    张臻
  • 依托单位:
基于染色体22q11.2候选基因与腭心面综合征表型的分子诊断研究
  • 批准号:
    81070813
  • 项目类别:
    面上项目
  • 资助金额:
    35.0万元
  • 批准年份:
    2010
  • 负责人:
    王国民
  • 依托单位:
无22q11.2区基因微缺失的心脏圆锥动脉干畸形患者中新TBX1突变体蛋白的功能研究
  • 批准号:
    81070135
  • 项目类别:
    面上项目
  • 资助金额:
    32.0万元
  • 批准年份:
    2010
  • 负责人:
    徐让
  • 依托单位: